Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer

Conditions:   Advanced Non Small Cell Lung Cancer;   Uterine Cancer;   Soft Tissue Sarcoma Interventions:   Drug: PD-1 inhibitor;   Drug: Apatinib Sponsors:   Hunan Cancer Hospital;   Jiangsu HengRui Medicine Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials